Perioral dermatitis guide: what it is, what causes it, and how to treat it

Perioral dermatitis is a common inflammatory facial skin condition that is frequently misdiagnosed and often inadvertently made worse by its own treatment. Here is the complete evidence-based guide.

What perioral dermatitis looks like

Perioral dermatitis presents as:
Small (1–3mm) papules and pustules clustered around the mouth — most commonly in the perioral crease and on the chin
A characteristic clear zone directly bordering the vermilion (lip line) — the rash typically does not touch the lip border itself, which helps distinguish it from contact dermatitis
Erythema (redness) and mild scaling in the affected area
Mild to moderate burning or itching sensation
Occasional spread to the nasolabial folds, nose (perinasal dermatitis), or eyes (periocular dermatitis)

Who gets it: Primarily affects women aged 20–45, though men and children are also affected. The childhood variant (often called perioral dermatitis of childhood) frequently involves the perinasal area.

---

The cause: topical corticosteroids

The single most important cause of perioral dermatitis is topical corticosteroid use on the face.

How steroids cause it

Topical steroids applied to the face (often for another condition — rosacea, eczema, acne, or simply to reduce redness) initially suppress the perioral inflammation
The skin becomes dependent on the steroid — its own anti-inflammatory mechanisms are suppressed
When the steroid is stopped, a rebound inflammatory flare occurs that is worse than the original condition
The patient, believing the redness is getting worse, reapplies the steroid — and the cycle continues

Over months to years of this cycle, the perioral skin develops a characteristic papulopustular eruption that does not resolve without completely stopping the steroid.

Inhaled steroids: Perioral dermatitis can occur from fluorinated inhaled corticosteroids (asthma inhalers) — residue deposits around the mouth after each inhalation. Rinsing the mouth and wiping the perioral skin after inhaler use reduces this risk.

Nasal steroids: Similar mechanism — nasal spray residue can deposit in the perioral area.

Fluorinated toothpaste: Some evidence implicates heavy fluoride exposure from toothpaste as a contributing factor; switching to non-fluorinated toothpaste may help in resistant cases (evidence is limited).

Cosmetics and moisturizers: Heavy, occlusive creams applied to the perioral area may contribute in susceptible individuals by creating an environment that promotes follicular inflammation. The association is less established than with steroids.

The rebound problem

The most critical concept in perioral dermatitis treatment: stopping topical steroids always causes an initial worsening before improvement begins. This rebound flare:
Begins within days of stopping the steroid
Peaks at approximately 1–2 weeks
Gradually resolves over 4–12 weeks with appropriate treatment
Is not a treatment failure — it is an expected and necessary part of recovery

Patients must be informed of the rebound flare in advance. Without this expectation, virtually all patients restart steroids during the rebound — which resets the clock and prolongs the condition indefinitely.

---

Distinguishing perioral dermatitis from similar conditions

| Feature | Perioral Dermatitis | Rosacea | Acne Vulgaris | Contact Dermatitis |
|---|---|---|---|---|
| Location | Perioral/perinasal/periocular | Central face (cheeks, nose, chin) | T-zone, forehead, back | Contact area (anywhere) |
| Clear lip border | Yes — characteristic | No | No | No |
| Flushing | No | Yes (erythematotelangiectatic type) | No | No |
| Comedones | No | No (rosacea) | Yes | No |
| Steroid history | Usually yes | May worsen with steroids | Sometimes | No |
| Itch vs. burn | Mild itch/burn | Burning/stinging | Minimal | Intense itch |

---

Treatment

Step 1: Stop all topical steroids — immediately and completely

Zero tolerance for facial steroids is the foundation of treatment. This is non-negotiable:
Discontinue immediately — do not taper, do not substitute a weaker steroid
Accept and explain the rebound flare
If a steroid was prescribed by another provider, inform them of the diagnosis change

Managing the rebound: The rebound flare is uncomfortable but not dangerous. Applying a plain emollient (unfragranced, non-occlusive) and using topical prescription treatment simultaneously helps manage the rebound period.

Step 2: Topical prescription treatment

Metronidazole 0.75% gel or cream: First-line topical for perioral dermatitis. Anti-inflammatory and antimicrobial; well-tolerated on facial skin. Apply once or twice daily to affected areas. Improvement typically begins at 4–6 weeks; full clearance at 8–12 weeks.

Azelaic acid 15–20% gel or cream: Second-line or combination option. Anti-inflammatory, antimicrobial, and mild antikeratinizing effects. Well-tolerated; appropriate for long-term use. Comparable to metronidazole in head-to-head evidence.

Ivermectin 1% cream (Soolantra): Originally approved for rosacea; increasingly used for perioral dermatitis. Anti-inflammatory and antiparasitic (targets Demodex mites, which may contribute to the inflammatory cascade in perioral dermatitis as in rosacea). Once daily application.

Clindamycin 1% lotion/gel: Topical antibiotic; useful when the pustular component is prominent. Less evidence than metronidazole for perioral dermatitis specifically.

Step 3: Oral antibiotics (moderate-severe disease)

For widespread, papulopustular, or refractory perioral dermatitis, oral tetracyclines are the most evidence-supported systemic treatment:

Doxycycline 50–100mg daily: 8–12 weeks. The anti-inflammatory mechanism (inhibition of MMP-9, IL-1, and TNF-α at sub-antimicrobial doses) — not the antibiotic effect — is the primary mechanism of benefit. Sub-antimicrobial dose doxycycline 40mg (Oracea) provides the anti-inflammatory benefit without promoting antibiotic resistance.

Minocycline 50–100mg daily: Alternative; similar efficacy.

Combine with topical metronidazole or azelaic acid; taper oral antibiotic at 8–12 weeks while maintaining topical treatment.

What to avoid during treatment

All topical corticosteroids — including very mild hydrocortisone 0.5%
Heavy, occlusive moisturizers in the perioral area
Fragranced products applied near the mouth
Fluorinated toothpaste in refractory cases (trial switch to fluoride-free)

---

Treatment timeline

| Timepoint | Expected status |
|---|---|
| Days 1–14 | Rebound flare — worse than baseline |
| Weeks 2–4 | Rebound resolving; papules beginning to reduce |
| Weeks 4–8 | Significant improvement; most pustules resolved |
| Weeks 8–12 | Near-clearance; residual erythema fading |
| 3–6 months | Full clearance in most patients |

Perioral dermatitis is fully reversible with correct treatment. Unlike rosacea, it does not typically cause permanent vascular or glandular changes. Complete clearance is the realistic outcome for most patients who adhere to the zero-steroid protocol.

---

Prevention of recurrence

Avoid all topical steroids on the facial skin indefinitely (or with extreme caution and minimum duration if medically necessary)
Rinse the mouth and wipe the perioral area after using inhaled or nasal steroids
Use gentle, non-occlusive skincare in the perioral area
Recognize early warning signs of recurrence — catch and treat early before the cycle re-establishes

---

Looking for a perioral dermatitis consultation? Browse med spa and dermatology providers on MedSpot →